2seventy bio, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
2seventy bio, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • 2seventy bio, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$27.1M, a 43.6% increase year-over-year.
  • 2seventy bio, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$216M, a 10.7% decline year-over-year.
  • 2seventy bio, Inc. annual Operating Income (Loss) for 2023 was -$238M, a 9.7% increase from 2022.
  • 2seventy bio, Inc. annual Operating Income (Loss) for 2022 was -$263M, a 16.2% increase from 2021.
  • 2seventy bio, Inc. annual Operating Income (Loss) for 2021 was -$314M, a 127% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$238M +$25.5M +9.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-07
2022 -$263M +$50.8M +16.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-07
2021 -$314M -$176M -127% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-07
2020 -$138M +$203M +59.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-16
2019 -$341M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.